Merck KGaA (OTCMKTS:MKKGY) Sees Large Volume Increase – What’s Next?

Merck KGaA (OTCMKTS:MKKGY) saw strong trading volume on Monday . 270,223 shares traded hands during mid-day trading, an increase of 197% from the previous session’s volume of 91,034 shares.The stock last traded at $30.06 and had previously closed at $30.46.

Analyst Ratings Changes

Several research firms recently commented on MKKGY. HSBC raised Merck KGaA to a “hold” rating in a report on Monday, July 6th. Jefferies Financial Group started coverage on Merck KGaA in a report on Tuesday, May 26th. They set a “hold” rating on the stock. UBS Group lowered shares of Merck KGaA from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 20th. Finally, Zacks Research downgraded shares of Merck KGaA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 20th. Six investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Merck KGaA currently has an average rating of “Hold”.

Merck KGaA Stock Performance

The firm’s fifty day moving average is $32.15 and its 200-day moving average is $29.58. The company has a current ratio of 1.51, a quick ratio of 1.00 and a debt-to-equity ratio of 0.36. The stock has a market capitalization of $19.51 billion, a PE ratio of 15.56, a price-to-earnings-growth ratio of 2.86 and a beta of 0.96.

About Merck KGaA

Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest pharmaceutical and chemical businesses. Merck KGaA operates independently from the U.S.-based Merck & Co, Inc, which uses the name MSD in markets outside the United States and Canada.

The company operates through three primary business sectors: Life Science, Healthcare and Electronics. Its Life Science business supplies laboratory products, research tools, bioprocessing equipment and services used by academic institutions, pharmaceutical manufacturers and other industrial customers.